PD-L2 is a second ligand for PD-1 and inhibits T cell activation
2001 · Nature Immunology · 2,923 citations
https://doi.org/10.1038/85330
T
Tatyana Chernova
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
53
Papers
13.5K
Citations
21
h-index
24
i10-index
Tatyana Chernova is an academic researcher from University of Cambridge. The author has contributed to research in topics: Occupational and environmental lung diseases & Neuroscience and Neuropharmacology Research & Heme Oxygenase-1 and Carbon Monoxide. The author has an h-index of 21, co-authored 46 publications.
Papers by this author
worksEndothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8<sup>+</sup> T cell activation and cytolysis
2003 · European Journal of Immunology · 470 citations
https://doi.org/10.1002/eji.200324270
Long-Fiber Carbon Nanotubes Replicate Asbestos-Induced Mesothelioma with Disruption of the Tumor Suppressor Gene Cdkn2a ( Ink4a/Arf )
2017 · Current Biology · 135 citations
https://doi.org/10.1016/j.cub.2017.09.007
Complex response to physiological and drug-induced hepatic heme demand in monoallelic ALAS1 mice
2021 · Molecular Genetics and Metabolism Reports · 2 citations
https://doi.org/10.1016/j.ymgmr.2021.100818
Author Correction: Integrated genomics point to immune vulnerabilities in pleural mesothelioma
2022 · Scientific Reports · 0 citations
https://doi.org/10.1038/s41598-022-08800-1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat